Prospective Database of Clinical Outcomes Following Cryotherapy for Ablation of Clinically Localized Prostate Cancer

Part of paid clinical trials in New York, New York.

Sponsor
NYU Langone Health
Study ID
NCT07184957
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
MALE
Age
40 Years - 85 Years
Healthy Volunteers
Not accepted

Study Details

This will be a prospectively maintained research database. The purpose is to record baseline parameters and treatment outcomes following of Cryotherapy for ablation of clinically localized prostate cancer.

Key Dates

Start date
May 1, 2017
Status verified
Sep 2025
Primary completion
Dec 31, 2030
Completion
Dec 31, 2040

Study Design

Enrollment
1,000 participants (estimated)

Arms

  • Arm: Men with Prostate Cancer
    Men who receive cryotherapy for ablation of clinically localized prostate cancer.

Primary Outcome Measure

Treatment Complications [ Time Frame: Up to Year 15 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
NYU Langone HealthNew YorkNew York10016-

Find similar trials in New York, NY

By condition
Prostate cancer
By specialty
OncologyProstate oncologyMen's healthUrology
By research site
NYU Langone Health· New York, NY

Related Studies